Your selection

Innovation / 27.03.2020
Eckert & Ziegler: Executive Board Proposes Dividend and Share Split

Eckert & Ziegler AG (ISIN DE0005659700, S-DAX), a specialist for isotope-based applications in medicine, science and industry achieved earnings per share of 4.29 EUR in the fiscal year 2019. At the General Shareholders’ Meeting the Executive Board and the Supervisory Board will propose a dividend of 1,70 EUR per share entitled to a dividend (previous year: 1.20 EUR per share).

In addition, the Executive Board and Supervisory Board today decided to propose to the Annual General Meeting a resolution to increase the share capital from company funds by EUR 15,878,949.00 from the current EUR 5,292,983.00 by EUR 15,878,949.00 to EUR 21,171,932.00 by issuing new shares (§§ 207 et seq. of the AktG) by way of converting free reserves into share capital of the company. In doing so, the shareholders of the Company shall receive three (3) new shares for each one (1) existing share.

The capital increase from company funds will not result in any changes to the shareholders' participations in the company. If the proposed resolutions are accepted by the General Meeting and the amendments to the Articles of Association are entered in the Commercial Register, each shareholder will be credited with the corresponding number of new shares in his or her securities account. The higher number of shares and the resulting reduction in the share price should make the Company's shares more liquid and even more attractive for investors.

The price of the Eckert & Ziegler share has risen continuously over the past few years. The aim of the increase in the share capital of Eckert & Ziegler AG from company funds by issuing new shares in a ratio of 1:3, to be proposed to the Annual General Meeting, is to make trading in the share more liquid and to make the share even more attractive for investors.    

The complete figures for the FY 2019 and the forecast for the current FY 2020 will be published on 31 March 2020.
In view of the current situation (COVID-19), a postponement of the Annual General Meeting currently planned for 17 June 2020 cannot be excluded.

Disclosure of inside information according to Article 17 MAR

www.ezag.de

Overview News

News Buch Berlin

From cell biology to CRISPR/Cas – new knowledge for schools

The Life Science Learning Lab at the Berlin-Buch research campus offers both school students and teachers the opportunity to immerse themselves in science. This year, the facility celebrates its 25th ...

more ...

ERC grants Berlin scientists € 2.5 million each

Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that u...

more ...

The Protein Expert

Prof. Dr. Fan Liu from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has recently received several awards for her contributions to the field of cross-linking mass spectrometry.

more ...

Events Buch Berlin

19.04.2024, 08:30
Lehrkräftekongress: Gemeinsam Schüler:innen für Naturwissenschaften begeistern - gemeinsam Zukunft gestalten

Der Verband der Chemischen Industrie e.V., Landesverband Nordost, das Max Delbrück Center, das Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V., das Gläserne La...

more ...

21.04.2024, 16:00
Großes Sinfoniekonzert "Durch die Nacht zum Licht"

Saisonauftakt der Bürgersinfonie mit Werken von Beethoven, Mendelssohn Bartholdy und Berwald

more ...

23.04.2024, 11:00
Kostenlose öffentliche Fahrrad-Codierung

Das Präventionsteam des Polizeiabschnittes 14 ist auf dem Campus Berlin-Buch und codiert kostenlos Fahrräder

more ...

This website is supported by: